Ergoteles’s Aptinyx Inc. Common Stock APTX Stock Holding History

Ergoteles’s Portfolio APTX Stock Details APTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-44,578	Closed	-$104K	–	1712
2021 Q3	$104K	Sell	44,578 -103,522	-70%	-$264K	﹤0.01%	1098
2021 Q2	$419K	Buy	+148,100	New	+$414K	0.01%	891

Other funds holding APTX

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

Ergoteles's APTX Position: Q4 2021 in Review

Ergoteles sold out of Aptinyx Inc. Common Stock (APTX) in Q4 2021, closing a stake of 44,578 shares — an estimated $104K sold.

Ergoteles first reported a position in APTX in Q2 2021 and held it in 2 quarters. The position peaked at $419K in Q2 2021. 49 funds tracked by Wall St. Rank hold APTX as of Q4 2021.

Ergoteles reported no remaining Aptinyx Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 44,578 Aptinyx Inc. Common Stock shares in Q4 2021, an estimated $104K.
Ergoteles first reported a position in Aptinyx Inc. Common Stock in Q2 2021 and held it in 2 quarters.
Ergoteles's Aptinyx Inc. Common Stock position peaked at $419K in Q2 2021.
49 funds tracked by Wall St. Rank held Aptinyx Inc. Common Stock as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.